VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Post by Whiskeytimeon Mar 03, 2017 11:38am

155 Views

Post# 25927087

Level 2

LEVEL 2 QUOTE

Shares	Bid Price	Ask Price	Shares
56,000	0.640	0.650	21,000
70,000	0.630	0.660	17,500
67,500	0.620	0.670	83,500
109,000	0.610	0.680	31,500
165,000	0.600	0.690	80,500
107,000	0.590	0.700	40,500
50,000	0.580	0.710	35,000
38,500	0.570	0.720	99,500
69,000	0.560	0.730	64,500
50,500	0.550	0.740	42,500